The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia Prepared by

ASGE Standards of Practice Committee

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this document that updates a previously issued consensus statement and a technology status evaluation report on this topic.1 In preparing this guideline, a search of the medical literature was performed by using PubMed between January 1975 and May 2015, with the use of the search terms "pancreatic AND malignancy," "endoscopy," "EUS," and "ERCP." Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data existed from welldesigned prospective trials, emphasis is given to results from large series and reports from recognized experts. Recommendations for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the documents are drafted. Further controlled clinical studies may be needed to clarify aspects of recommendations contained in this document. This document may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence. The strength of individual recommendations is based both on the aggregate evidence quality and an assessment of the anticipated benefits and harms. Weaker recommendations are indicated by phrases such as "we suggest," whereas stronger recommendations are typically stated as "we recommend." This guideline is intended to be an educational device to provide information that may assist endoscopists in providing care to patients. It is not a rule and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment. Clinical decpuraging any particular case involve a complex analysis of the patient's condition and available courses of action. Therefore, clinical considerations may lead anendoscopist to take a course of action that varies from these recommendations and suggestions.

Original languageEnglish (US)
Pages (from-to)17-28
Number of pages12
JournalGastrointestinal Endoscopy
Volume83
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Endoscopy
Guidelines
Technology
Neoplasms
Gastrointestinal Endoscopy
Endoscopic Retrograde Cholangiopancreatography
Bibliography
Standard of Care
Consultants
PubMed
Patient Care
Equipment and Supplies
Therapeutics
Clinical Studies

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia Prepared by. / ASGE Standards of Practice Committee.

In: Gastrointestinal Endoscopy, Vol. 83, No. 1, 01.01.2016, p. 17-28.

Research output: Contribution to journalArticle

@article{cc771120fdca4ed58415737bf281e43d,
title = "The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia Prepared by",
abstract = "This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this document that updates a previously issued consensus statement and a technology status evaluation report on this topic.1 In preparing this guideline, a search of the medical literature was performed by using PubMed between January 1975 and May 2015, with the use of the search terms {"}pancreatic AND malignancy,{"} {"}endoscopy,{"} {"}EUS,{"} and {"}ERCP.{"} Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data existed from welldesigned prospective trials, emphasis is given to results from large series and reports from recognized experts. Recommendations for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the documents are drafted. Further controlled clinical studies may be needed to clarify aspects of recommendations contained in this document. This document may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence. The strength of individual recommendations is based both on the aggregate evidence quality and an assessment of the anticipated benefits and harms. Weaker recommendations are indicated by phrases such as {"}we suggest,{"} whereas stronger recommendations are typically stated as {"}we recommend.{"} This guideline is intended to be an educational device to provide information that may assist endoscopists in providing care to patients. It is not a rule and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment. Clinical decpuraging any particular case involve a complex analysis of the patient's condition and available courses of action. Therefore, clinical considerations may lead anendoscopist to take a course of action that varies from these recommendations and suggestions.",
author = "{ASGE Standards of Practice Committee} and Eloubeidi, {Mohamad A.} and Decker, {G. Anton} and Vinay Chandrasekhara and Chathadi, {Krishnavel V.} and Early, {Dayna S.} and Evans, {John A.} and Fanelli, {Robert D.} and Fisher, {Deborah A.} and Kimberly Foley and Hwang, {Joo Ha} and Jue, {Terry L.} and Lightdale, {Jenifer R.} and Pasha, {Shabana F.} and Saltzman, {John R.} and Ravi Sharaf and Shergill, {Amandeep K.} and Cash, {Brooks D.} and John DeWitt",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.gie.2015.09.009",
language = "English (US)",
volume = "83",
pages = "17--28",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia Prepared by

AU - ASGE Standards of Practice Committee

AU - Eloubeidi, Mohamad A.

AU - Decker, G. Anton

AU - Chandrasekhara, Vinay

AU - Chathadi, Krishnavel V.

AU - Early, Dayna S.

AU - Evans, John A.

AU - Fanelli, Robert D.

AU - Fisher, Deborah A.

AU - Foley, Kimberly

AU - Hwang, Joo Ha

AU - Jue, Terry L.

AU - Lightdale, Jenifer R.

AU - Pasha, Shabana F.

AU - Saltzman, John R.

AU - Sharaf, Ravi

AU - Shergill, Amandeep K.

AU - Cash, Brooks D.

AU - DeWitt, John

PY - 2016/1/1

Y1 - 2016/1/1

N2 - This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this document that updates a previously issued consensus statement and a technology status evaluation report on this topic.1 In preparing this guideline, a search of the medical literature was performed by using PubMed between January 1975 and May 2015, with the use of the search terms "pancreatic AND malignancy," "endoscopy," "EUS," and "ERCP." Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data existed from welldesigned prospective trials, emphasis is given to results from large series and reports from recognized experts. Recommendations for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the documents are drafted. Further controlled clinical studies may be needed to clarify aspects of recommendations contained in this document. This document may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence. The strength of individual recommendations is based both on the aggregate evidence quality and an assessment of the anticipated benefits and harms. Weaker recommendations are indicated by phrases such as "we suggest," whereas stronger recommendations are typically stated as "we recommend." This guideline is intended to be an educational device to provide information that may assist endoscopists in providing care to patients. It is not a rule and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment. Clinical decpuraging any particular case involve a complex analysis of the patient's condition and available courses of action. Therefore, clinical considerations may lead anendoscopist to take a course of action that varies from these recommendations and suggestions.

AB - This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this document that updates a previously issued consensus statement and a technology status evaluation report on this topic.1 In preparing this guideline, a search of the medical literature was performed by using PubMed between January 1975 and May 2015, with the use of the search terms "pancreatic AND malignancy," "endoscopy," "EUS," and "ERCP." Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data existed from welldesigned prospective trials, emphasis is given to results from large series and reports from recognized experts. Recommendations for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the documents are drafted. Further controlled clinical studies may be needed to clarify aspects of recommendations contained in this document. This document may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence. The strength of individual recommendations is based both on the aggregate evidence quality and an assessment of the anticipated benefits and harms. Weaker recommendations are indicated by phrases such as "we suggest," whereas stronger recommendations are typically stated as "we recommend." This guideline is intended to be an educational device to provide information that may assist endoscopists in providing care to patients. It is not a rule and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment. Clinical decpuraging any particular case involve a complex analysis of the patient's condition and available courses of action. Therefore, clinical considerations may lead anendoscopist to take a course of action that varies from these recommendations and suggestions.

UR - http://www.scopus.com/inward/record.url?scp=84952324422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952324422&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2015.09.009

DO - 10.1016/j.gie.2015.09.009

M3 - Article

C2 - 26706297

AN - SCOPUS:84952324422

VL - 83

SP - 17

EP - 28

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 1

ER -